These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10126866)

  • 1. A pharmacoeconomic evaluation of clozapine in one patient.
    Rémillard AJ; Johnson JA
    Can J Hosp Pharm; 1993 Jun; 46(3):115-9. PubMed ID: 10126866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New vs. old antipsychotics: the Texas experience.
    Reid WH
    J Clin Psychiatry; 1999; 60 Suppl 1():23-5; discussion 28-30. PubMed ID: 10037167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacoeconomic evaluation of treatments for refractory schizophrenia: clozapine-related studies.
    Revicki DA
    J Clin Psychiatry; 1999; 60 Suppl 1():7-11; discussion 28-30. PubMed ID: 10037164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clozapine for refractory schizophrenia: the Illinois experience.
    Buckman RW; Malan RD
    J Clin Psychiatry; 1999; 60 Suppl 1():18-22; discussion 28-30. PubMed ID: 10037166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacoeconomics of clozapine: a review.
    Meltzer HY; Cola PA
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():161-5. PubMed ID: 7961564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outpatient antipsychotic treatment and inpatient costs of schizophrenia.
    Marcus SC; Olfson M
    Schizophr Bull; 2008 Jan; 34(1):173-80. PubMed ID: 17578893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pharmacoeconomic analysis of atypical antipsychotics and haloperidol in first-episode schizophrenic patients in taiwan.
    Gau SS; Chung CH; Gau CS
    J Clin Psychopharmacol; 2008 Jun; 28(3):271-8. PubMed ID: 18480683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Looking beyond the formulary budget in cost-benefit analysis.
    Cohen LJ
    Am J Manag Care; 1997 Feb; 3 Suppl():S11-7. PubMed ID: 10180337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacoeconomic evaluation of clozapine in treatment-resistant schizophrenia: a cost-utility analysis.
    Oh PI; Iskedjian M; Addis A; Lanctôt K; Einarson TR
    Can J Clin Pharmacol; 2001; 8(4):199-206. PubMed ID: 11743592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generic replacement of clozapine: a simple decision model from a Canadian perspective.
    Layton S; Barbeau M
    Curr Med Res Opin; 2004 Apr; 20(4):453-9. PubMed ID: 15119982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health care resource use associated with integrated psychological treatment.
    Vasiliadis HM; Briand C; Lesage A; Reinharz D; Stip E; Nicole L; Lalonde P
    J Ment Health Policy Econ; 2006 Dec; 9(4):201-7. PubMed ID: 17200597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Migration, mental health and costs consequences in Romania.
    Miclutia I; Junjan V; Popescu CA; Tigan S
    J Ment Health Policy Econ; 2007 Mar; 10(1):43-50. PubMed ID: 17417046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antipsychotic medication use patterns and associated costs of care for individuals with schizophrenia.
    Loosbrock DL; Zhao Z; Johnstone BM; Morris LS
    J Ment Health Policy Econ; 2003 Jun; 6(2):67-75. PubMed ID: 14578539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.
    Wheeler AJ
    Ann Pharmacother; 2008 Jun; 42(6):852-60. PubMed ID: 18477732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical effects of a randomized switch of patients from clozaril to generic clozapine.
    Kluznik JC; Walbek NH; Farnsworth MG; Melstrom K
    J Clin Psychiatry; 2001; 62 Suppl 5():14-7; discussion 23-4. PubMed ID: 11305843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The health and cost effects of substituting home care for inpatient acute care: a review of the evidence.
    Soderstrom L; Tousignant P; Kaufman T
    CMAJ; 1999 Apr; 160(8):1151-5. PubMed ID: 10234345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is clozapine cost-effective? Unanswered issues.
    Seshamani M
    Eur J Health Econ; 2002 Nov; 3 Suppl 2():S104-13. PubMed ID: 15609156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clozapine's cost effectiveness.
    Rosenheck R; Charney DS; Frisman LK; Cramer J
    Am J Psychiatry; 1995 Jan; 152(1):152-3. PubMed ID: 7802113
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacoeconomic and health outcome comparison of lithium and divalproex in a VA geriatric nursing home population: influence of drug-related morbidity on total cost of treatment.
    Conney J; Kaston B
    Am J Manag Care; 1999 Feb; 5(2):197-204. PubMed ID: 10346515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cost of home hospice care for terminal patients in Israel.
    Shnoor Y; Szlaifer M; Aoberman AS; Bentur N
    Am J Hosp Palliat Care; 2007; 24(4):284-90. PubMed ID: 17601831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.